| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SCMH1_0010000 | Exon-Exon | chr1:41579038-41608678 | chr1:41113366-41143006 | 379 nt | 0.5224 |
| hsa_SCMH1_0010100 | Exon-Exon | chr1:41579082-41608784 | chr1:41113410-41143112 | 441 nt | 0.5125 |
| hsa_SCMH1_0010200 | Exon-Exon | chr1:41579097-41608647 | chr1:41113425-41142975 | 289 nt | 0.4913 |
| hsa_SCMH1_0010300 | Intron-Intron | chr1:41579263-41582593 | chr1:41113591-41116921 | 250 nt | 0.2640 |
| hsa_SCMH1_0010400 | Exon-Exon | chr1:41582594-41608784 | chr1:41116922-41143112 | 324 nt | 0.5093 |
| hsa_SCMH1_0010500 | Exon-Exon | chr1:41582594-41626570 | chr1:41116922-41160898 | 24 nt | 0.5000 |
| hsa_SCMH1_0010600 | Exon-Exon | chr1:41582594-41627104 | chr1:41116922-41161432 | 158 nt | 0.4430 |
| hsa_SCMH1_0010700 | Intron-Intron | chr1:41583215-41583437 | chr1:41117543-41117765 | 223 nt | 0.4798 |
| hsa_chr1_0871000 | Intergenic-Intergenic | chr1:41586508-41586735 | chr1:41120836-41121063 | 228 nt | 0.3728 |
| hsa_SCMH1_0010800 | Intron-Exon-Intron | chr1:41589635-41617356 | chr1:41123963-41151684 | 46 nt | 0.4565 |
A study in humans demonstrated that the circSCMH1 is significantly decreased in the plasma of patients with acute ischemic stroke and is significant in predicting stroke outcomes [Wei et al. DOI:10.1186/s12883-021-02397-0]. A study in mice demonstrated that exosomes from adipose-derived stem cells delivering the circSCMH1 reduced nerve damage by promoting microglial M2 polarization [Li et al. DOI:10.1016/j.neuint.2023.105643].